Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2007-11-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will determine specific corneal neovascularization (CN) patterns in human corneal allograft recipients to determine the characteristics that worsen the prognosis for graft survival. We will test the hypothesis that specific characteristics of CN are prognostic for corneal allograft rejection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty
NCT04490902
Cornea Preservation Time Study
NCT01537393
Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy
NCT00633503
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
NCT06753916
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
NCT05809245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PKP
Subjects undergoing penetrating keratoplasty
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roni Shtein
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roni Shtein, MD, MS
Role: PRINCIPAL_INVESTIGATOR
University Of Michigam Kellogg Eye Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kellogg Eye Center
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neovasc-6281
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.